NCT00797394

Efficacy of Natural Extract 2007RD01 Combined With Saw Palmetto in Benign Prostatic Hyperplasia Patients Compared to Saw Palmetto

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 110 (estimated)
• Sponsor: innoVactiv Inc. · Industry
• Sex: Male
• Age: 50 Years – 75 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to determine if the combination of 2007RD01, a natural extract, and saw palmetto lipidic extract, is more effective at treating lower urinary tract symptoms associated with benign prostatic hyperplasia than saw palmetto lipidic extract alone.

Conditions

• Benign Prostatic Hyperplasia

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	Combination of 2007RD01 and saw palmetto lipidic extract	Oral administration of one capsule containing a combination of 250 mg of 2007RD01 (a natural extract) and 160 mg of saw palmetto lipidic extract plus inactive fillers, twice a day between meals
DIETARY_SUPPLEMENT	Saw palmetto lipidic extract	Oral administration of one capsule of 160 mg of saw palmetto lipidic extract plus inactive fillers, twice a day between meals

Timeline

• Start date: 2008-11-01
• Primary completion: 2010-07-01
• First posted: 2008-11-25
• Last updated: 2011-04-13

Locations

4 sites across 1 country: Canada